0% found this document useful (0 votes)
166 views12 pages

Modern Drug Discovery Process

The modern drug discovery process involves several key stages: target identification, target validation, lead discovery, lead optimization, pre-clinical development, and clinical development. This process is complex and expensive, with costs ranging from $897 million to $1.9 billion per drug. Each stage focuses on identifying and optimizing compounds that can effectively treat diseases through various biochemical interactions.

Uploaded by

Payal Devda
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
166 views12 pages

Modern Drug Discovery Process

The modern drug discovery process involves several key stages: target identification, target validation, lead discovery, lead optimization, pre-clinical development, and clinical development. This process is complex and expensive, with costs ranging from $897 million to $1.9 billion per drug. Each stage focuses on identifying and optimizing compounds that can effectively treat diseases through various biochemical interactions.

Uploaded by

Payal Devda
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd

Principles ofDrug Discovery

MODERN DRUG DISCOVERY PROCESS


Prof SaurabhGupta
 PYQ Que.
Explain the stagesinvolved in modern drug discoveryprocess.
(summer 2019)
Introduction
 Drug discovery is therapeutically useful in treating and curing a disease.
 Modern Drug Discovery Process is a process of identifyinga compound therapeutically
useful in treating and curing adisease.
 It Involves the identification of :
¸ Candidates
¸ Synthesis
¸ Characterization
¸ Screening and
¸ Assays for therapeutic efficacy.

 It is an Expensive process due to the high costs of R&D and human clinical tests.

 The average total costperdrug developmentvaries from US $ 897 million to US$ 1.9
billion.
Stepsin ModernDrugDiscovery
Step1:TargetIdentification
• A drug target is the specific binding site of a drug
throughwhichthe drug exerts itsaction.
• Characteristicsof Target are studied
• The drug target is a receptor, normallya protein.
• The receptor structure change when the Compound
binds to receptor.
• Due to change in the receptor structure various
physiological responsesoccur and induce regulationof
the cell, organ, tissue, or body status.
• Small moleculesbinding to the receptorsare drugs.
Step2:Targetvalidation
• Target validation is a process by whichthe predicted molecular target ( protein or nucleic acid) is verified
• it prove that manipulating the moleculartarget can provide therapeutic benefit forpatients.
• Target validationprocess might include following steps:
¸ Discovering a receptor of interest.
¸ Valuating its potential as a target
¸ Designing a bioassay to measure biological activity.
¸ Constructinga high-throughput screen.
¸ Performing screening to find hits.
¸ Evaluatingthe hits
• Biochemical classes of drug target
¸ G-Protein coupledreceptors-45%
¸ Enzymes-28%
¸ Hormones and factors-11%
¸ Ion channels -5%
¸ Nuclearreceptors -2%
Step3:Leaddiscovery
• Lead is a compound that shows possibilities as a treatment for a
disease and may leads the development of new drug
• lead generation phase, help to predict the possible profile of new
drugs in patients.
• The compounds selected are called “leads".
• Between 5 and 50000 compounds are examined in the laboratory,
of which only 100 to 200 are perfected in order to be tested on
systems in vitro and in vivo.
Step4:Leadoptimization
• Molecules are chemicallymodified in order to obtain compounds withsuitable properties to
become a drug.
• Lead optimization is a process that begins witha compound thatdisplays anbiological action and
ends withthe identification ofthe best analog.
• Leads are characterized with respect to pharmacodynamic such as efficacy and potency in vitro
and in vivo, Physiochemical properties, pharmacokinetic properties,and toxicological aspects.
• Potency- refers to the amount ofdrug required for its specific effect to occur.
• Efficacy - measures the maximumstrengthof the effect itself,at saturating drug concentrations.
• Pharmacokinetics - Itexplains about"What the bodydoes to the drug".Itoften divided into areas
examining the extent and rate of adsorption,distribution, metabolism, and excretion(ADME).
• Pharmacodynamic- It determines the biochemical and physiological effects of drugs,the
mechanismof drug action and the rela
about "What the drug does to the body".tionship betweendrug concentrationand effect. It explains
Step5:Pre-clinicaldevelopment
• The pre-clinical developmentincludes the following:
¸ developlarge scale synthesis
¸ animal safetystudies
¸ carcinogenicitytests
¸ drug delivery
¸ eliminationand metabolism studies
¸ drug formulation experiments
¸ dose-ranging studies in animals.
Wide ranging dosages ofthe compounds are introduced to the cell line or animal inorder toobtain
preliminaryefficacyand pharmacokinetic information.
¸
Step6:Clinicaldevelopment
• Treatment trials:
test experimental treatments or a newcombination ofdrugs.
• Prevention trials:
look for ways to prevent a disease or prevent it fromreturning.
• Diagnostic trials:
find better testor procedures for diagnosing a disease.
• Screening trials:
test methods of detecting diseases.
• Qualityof life trials:
explore ways to improve comfort& quality of life for individuals with a chronic illness
Reference:
• Principles of Drug Discovery by Padmaja kore first edition

• Chapter 41- Modern drug discovery and Development ScienceDirect


Article

You might also like